Schedule 13G ownership disclosure
Cytek Biosciences Inc
Common Stock, $0.001 Par Value Per Share · CUSIP: 23285D109
Event date: 2025-03-31
- Filing-level shares
- 7,463,967.00
- Percent of class
- 5.89%
- Brown Capital Management, LLC
Shares: 7,463,967.00 · Class: 5.89%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001398344-25-009599
- Form type
- SCHEDULE 13G/A
- Filer
- BROWN CAPITAL MANAGEMENT LLC
- CIK
- CIK 885062
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership